VACC insider filings
Vaccitech plc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-28. Screen VACC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for VACC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Vaccitech plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-06-28 | 4 | Scheeren Joseph — Director | Purchase (P): 10,000 @ $2.44 | EDGAR |
| 2023-06-01 | 4 | Wright Robin — Director | Purchase (P): 13,750 @ $2.66 | EDGAR |
| 2023-05-12 | 4 | Wright Robin — Director | Grant/award (A): 19,197 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | Scheeren Joseph — Director | Grant/award (A): 19,197 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | Morgon Pierre A. — Director | Grant/award (A): 19,197 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | Hammacher Alex — Director | Grant/award (A): 19,197 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | Phillips Anne M. — Director | Grant/award (A): 19,197 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | DAWES KAREN A — Director | Grant/award (A): 19,197 (derivative) @ $0 | EDGAR |
| 2023-03-29 | 4 | Marshall Margaret — Chief Medical Officer | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2023-03-29 | 4 | Evans Thomas George — Fmr Chief Scientific Officer | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-03-29 | 4 | Enright William — Chief Executive Officer, Director | Sale (S): 15,000 @ $2.42 | EDGAR |
| 2023-02-24 | 4 | Pelletier Nadege — Chief Scientific Officer | Grant/award (A): 485,000 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Ellis Christopher — Chief Operating Officer | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Griffiths Graham — Chief Business Officer | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Brown Gemma — Chief Financial Officer | Grant/award (A): 33,100 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Enright William — Chief Executive Officer, Director | Grant/award (A): 440,000 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | M&G Alternatives Investment Management Ltd — 10% owner | Other (J): 4,108,752 @ $0 | EDGAR |
| 2022-10-04 | 4 | M&G INVESTMENT MANAGEMENT LTD — 10% owner | Other (J): 4,108,752 @ $0 | EDGAR |
| 2022-09-28 | 4 | Brown Gemma — Chief Financial Officer | Grant/award (A): 334,000 (derivative) @ $0 | EDGAR |
| 2022-08-26 | 4 | Griffiths Graham — Chief Business Officer | Sale (S): 10,000 @ $7.39 | EDGAR |
| 2022-08-26 | 4 | Ellis Christopher — Chief Operating Officer | Option exercise (M): 450 @ $0.00 · Sale (S): 450 @ $4.78 · Option exercise (M): 39,176 @ $0.00 · Sale (S): 14,176 @ $5.69 · Sale (S): 25,000 @ $7.07 · Option exercise (M): 450 (derivative) @ $0 · +1 more | EDGAR |
| 2022-08-19 | 4 | Ellis Christopher — Chief Operating Officer | Option exercise (M): 649 @ $0.00 · Sale (S): 649 @ $4.77 · Option exercise (M): 2,175 @ $0.00 · Sale (S): 2,175 @ $4.84 · Option exercise (M): 649 (derivative) @ $0 · Option exercise (M): 2,175 (derivative) @ $0 | EDGAR |
| 2022-08-19 | 4 | Griffiths Graham — Chief Business Officer | Sale (S): 500 @ $4.76 | EDGAR |
| 2022-08-17 | 4 | Ellis Christopher — Chief Operating Officer | Option exercise (M): 5,350 @ $0.00 · Sale (S): 5,350 @ $4.76 · Option exercise (M): 2,200 @ $0.00 · Sale (S): 2,200 @ $4.78 · Option exercise (M): 5,350 (derivative) @ $0 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2022-08-17 | 4 | Griffiths Graham — Chief Business Officer | Sale (S): 2,400 @ $4.75 · Sale (S): 1,220 @ $4.82 | EDGAR |
| 2022-08-15 | 4 | Griffiths Graham — Chief Business Officer | Sale (S): 5,000 @ $4.50 | EDGAR |
| 2022-07-15 | 4 | Ellis Christopher — Chief Operating Officer | Option exercise (M): 5 @ $0.00 · Sale (S): 5 @ $6 · Option exercise (M): 5 (derivative) @ $0 | EDGAR |
| 2022-07-15 | 4 | Griffiths Graham — Chief Business Officer | Option exercise (M): 1,931 @ $0.00 · Option exercise (M): 2,317 @ $0.00 · Option exercise (M): 3,090 @ $0.00 · Sale (S): 8 @ $5.28 · Code (L): 100 @ $5.87 · Option exercise (M): 1,931 (derivative) @ $0 · +2 more | EDGAR |
| 2022-04-04 | 4 | Scheeren Joseph — Director | Purchase (P): 10,000 @ $5.09 | EDGAR |
| 2022-04-04 | 4 | Hammacher Alex — Director | Purchase (P): 2,000 @ $5.14 | EDGAR |
| 2022-02-11 | 4 | Marshall Margaret — Chief Medical Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4 | Griffiths Graham — Chief Business Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4 | Evans Thomas George — Chief Scientific Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4 | Ellis Christopher — Chief Operating Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4 | Egorov Georgy — Chief Financial Officer | Grant/award (A): 114,000 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4 | Enright William — Chief Executive Officer, Director | Grant/award (A): 359,605 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | Hammacher Alex — Director | Purchase (P): 1,000 @ $10.86 | EDGAR |
| 2021-12-23 | 4 | Wright Robin — Director | Purchase (P): 10,000 @ $9.97 | EDGAR |
| 2021-05-07 | 4/A | Enright William — Chief Executive Officer, Director | Grant/award (A): 514,923 | EDGAR |
| 2021-05-06 | 4 | Griffiths Graham — Chief Business Officer | Purchase (P): 100 @ $17 | EDGAR |
| 2021-05-06 | 4 | Wright Robin — Director | Purchase (P): 14,000 @ $17 | EDGAR |
| 2021-05-06 | 4 | Ellis Christopher — Chief Operating Officer | Purchase (P): 75 @ $17 | EDGAR |
| 2021-05-06 | 4 | Scheeren Joseph — Director | Purchase (P): 3,000 @ $17 | EDGAR |
| 2021-05-06 | 4 | Oxford Sciences Innovation plc — 10% owner | Conversion (C): 4,832,142 · Conversion (C): 1,704,444 · Conversion (C): 1,661,184 · Purchase (P): 600,000 @ $17 · Conversion (C): 4,832,142 (derivative) · Conversion (C): 1,704,444 (derivative) · +1 more | EDGAR |
| 2021-05-06 | 4 | Phillips Anne M. — Director | Purchase (P): 3,000 @ $17 | EDGAR |
| 2021-05-06 | 4 | DAWES KAREN A — Director | Purchase (P): 1,700 @ $17 | EDGAR |
| 2021-05-04 | 4 | Egorov Georgy — Chief Financial Officer | Grant/award (A): 6,918 (derivative) @ $0 · Grant/award (A): 149,865 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | Enright William — Chief Executive Officer, Director | Grant/award (A): 455,775 · Grant/award (A): 176,130 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | Phillips Anne M. — Director | Grant/award (A): 34,328 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | DAWES KAREN A — Director | Grant/award (A): 34,328 (derivative) @ $0 | EDGAR |
Recent 8-K events — Vaccitech plc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-09 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-01 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events | EDGAR |
| 2026-08-25 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2026-05-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-31 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VACC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs